Literature DB >> 18696210

Ground-glass opacities showing an adenoma-to-carcinoma sequence in the lung.

Haruhiko Nakamura1, Takeshi Hirata, Masahiko Taguchi, Hajime Kitamura.   

Abstract

We encountered a patient with three left lower lobe pulmonary tumors evident as discrete ground-glass opacities by computed tomography. Pathological diagnoses of the resected lesions included a focus of atypical adenomatous hyperplasia (AAH) and two localized noninvasive bronchioloalveolar carcinomas (BACs) of types A and C according to Noguchi's classification. This case supports the hypothesis of an adenoma-to-carcinoma sequence in the lung, as the coexisting lesions represented sequential adenocarcinoma progression from a precancerous lesion, AAH, to very early-stage adenocarcinoma, noninvasive BAC.

Entities:  

Mesh:

Year:  2008        PMID: 18696210     DOI: 10.1007/s11748-008-0262-7

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  10 in total

1.  Glandular neoplasia of the lung. A proposed analogy to colonic tumors.

Authors:  R R Miller; B Nelems; K G Evans; N L Müller; D N Ostrow
Journal:  Cancer       Date:  1988-03-01       Impact factor: 6.860

2.  Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung.

Authors:  Luca Morandi; Sofia Asioli; Alberto Cavazza; Annalisa Pession; Stefania Damiani
Journal:  Lung Cancer       Date:  2007-01-22       Impact factor: 5.705

3.  Multiple lung adenocarcinomas showing ground-glass opacities on thoracic computed tomography.

Authors:  Yukio Tsushima; Kenji Suzuki; Shun-ichi Watanabe; Masahiko Kusumoto; Koji Tsuta; Yoshihiro Matsuno; Hisao Asamura
Journal:  Ann Thorac Surg       Date:  2006-10       Impact factor: 4.330

4.  The prognosis of resected lung carcinoma associated with atypical adenomatous hyperplasia: a comparison of the prognosis of well-differentiated adenocarcinoma associated with atypical adenomatous hyperplasia and intrapulmonary metastasis.

Authors:  K Suzuki; K Nagai; J Yoshida; T Yokose; T Kodama; K Takahashi; M Nishimura; H Kawasaki; M Yokozaki; Y Nishiwaki
Journal:  Cancer       Date:  1997-04-15       Impact factor: 6.860

5.  EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib.

Authors:  William Pao; Vincent Miller; Maureen Zakowski; Jennifer Doherty; Katerina Politi; Inderpal Sarkaria; Bhuvanesh Singh; Robert Heelan; Valerie Rusch; Lucinda Fulton; Elaine Mardis; Doris Kupfer; Richard Wilson; Mark Kris; Harold Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-25       Impact factor: 11.205

6.  Video-assisted thoracic surgery for pure ground-glass opacities 2 cm or less in diameter.

Authors:  Shunsuke Yamada; Tadasu Kohno
Journal:  Ann Thorac Surg       Date:  2004-06       Impact factor: 4.330

7.  Lung cancer patients showing pure ground-glass opacity on computed tomography are good candidates for wedge resection.

Authors:  Haruhiko Nakamura; Hisashi Saji; Akihiko Ogata; Takamoto Saijo; Shinya Okada; Harubumi Kato
Journal:  Lung Cancer       Date:  2004-04       Impact factor: 5.705

8.  Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.

Authors:  Joel F Gradowski; Geeta S Mantha; Jennifer L Hunt; Sanja Dacic
Journal:  Diagn Mol Pathol       Date:  2007-06

9.  Epidermal growth factor receptor gene mutations in early pulmonary adenocarcinomas.

Authors:  Haruhiko Nakamura; Norihito Kawasaki; Masahiko Taguchi; Harubumi Kato
Journal:  Ann Thorac Cardiovasc Surg       Date:  2007-04       Impact factor: 1.520

10.  Small adenocarcinoma of the lung. Histologic characteristics and prognosis.

Authors:  M Noguchi; A Morikawa; M Kawasaki; Y Matsuno; T Yamada; S Hirohashi; H Kondo; Y Shimosato
Journal:  Cancer       Date:  1995-06-15       Impact factor: 6.860

  10 in total
  1 in total

Review 1.  Clinical impact of the new IASLC/ATS/ERS lung adenocarcinoma classification for chest surgeons.

Authors:  Haruhiko Nakamura; Masayuki Takagi
Journal:  Surg Today       Date:  2014-11-23       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.